TARDBP and amyotrophic lateral sclerosis: The most documented post-translational modifications in ALS patients are phosphorylation in serine-409 and serine-410 [29,30], but other phosphorylated sites of pathological TDP-43 have also been described, such as serine-379, 403, and 404 [29,31,32].